Literature DB >> 30366007

Contemporary Guidelines in Whole-Breast Irradiation: An Alternative Perspective.

Abram Recht1, Heather McArthur2, Lawrence J Solin3, Rahul Tendulkar4, Alexander Whitley5, Armando Giuliano6.   

Abstract

The American Society for Radiation Oncology produced an evidence-based guideline on whole-breast radiation therapy for patients with early-stage invasive breast cancer and ductal carcinoma in situ. This commentary points out areas where we believe the data are too limited to make definitive recommendations and where alternative approaches are supported by evidence.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2018        PMID： 30366007     DOI： 10.1016/j.ijrobp.2018.10.014

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


  5 in total

1.  Disease Control After Hypofractionation Versus Conventional Fractionation for Triple Negative Breast Cancer: Comparative Effectiveness in a Large Observational Cohort.

Authors:  Reshma Jagsi; Kent A Griffith; Frank A Vicini; Eyad Abu-Isa; Derek Bergsma; Amit Bhatt; Joshua T Dilworth; Michael Dominello; Stephen Franklin; David K Heimburger; Isaac Kaufman; Paul G Kocheril; Annette E Kretzler; Peter Paximadis; Jeffrey D Radawski; Eleanor M Walker; Lori Pierce
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-10-28       Impact factor: 7.038

Review 2.  Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward.

Authors:  David Krug; René Baumann; Stephanie E Combs; Marciana Nona Duma; Jürgen Dunst; Petra Feyer; Rainer Fietkau; Wulf Haase; Wolfgang Harms; Thomas Hehr; Marc D Piroth; Felix Sedlmayer; Rainer Souchon; Vratislav Strnad; Wilfried Budach
Journal:  Strahlenther Onkol       Date:  2021-01-28       Impact factor: 3.621

3.  Screening of Specific and Common Pathways in Breast Cancer Cell Lines MCF-7 and MDA-MB-231 Treated with Chlorophyllides Composites.

Authors:  Keng-Shiang Huang; Yi-Ting Wang; Omkar Byadgi; Ting-Yu Huang; Mi-Hsueh Tai; Jei-Fu Shaw; Chih-Hui Yang
Journal:  Molecules       Date:  2022-06-20       Impact factor: 4.927

4.  Physician trajectories of abandoning long-course breast radiotherapy and their cost impact.

Authors:  Xiao Xu; Pamela R Soulos; Jeph Herrin; Shi-Yi Wang; Craig Evan Pollack; Suzanne B Evans; James B Yu; Cary P Gross
Journal:  Health Serv Res       Date:  2020-10-18       Impact factor: 3.734

5.  Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer.

Authors:  David Krug; Christine Köder; Matthias F Häfner; Nathalie Arians; Semi B Harrabi; Stefan A Koerber; Tobias Forster; Ingmar Schlampp; Christof Sohn; Joerg Heil; Holger Hof; Juliane Hörner-Rieber; Jürgen Debus
Journal:  Radiat Oncol       Date:  2020-10-13       Impact factor: 3.481
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.